Misinformation about prostate cancer is widespread in online networks and commonly raised during clinical encounters. Failing to address information can result in harms for patients, and challenging discussions about misinformation can lead to discord in the patient-clinician relationship.

There are many evidence-based recommendations for nutrition and lifestyle in prostate cancer. Failure to counsel patients on nutrition and lifestyle leads to lower quality of care.

Metastasis is the final common lethal pathway for most cancer patient's demise and once cancer has metastasized, it was generally considered incurable.

This activity covers updates and evolving data in treating biochemically recurrent prostate cancer post-prostatectomy. One speaker covers fractionation: can we safely hypofractionate in the post-operative setting, or is the data more supportive of conventional fractionation?

Numerous randomized trials have studied the benefit of adding androgen deprivation therapy (ADT) and/or prolonging its duration when treating localized prostate cancer with radiotherapy, while other trials have interrogated the benefit of escalating radiotherapy dose itself.